Your browser doesn't support javascript.
loading
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.
Liu, Hao; D'Alesio, Mark; AlMasri, Samer; Hammad, Abdulrahman; Desilva, Annissa; Lebowitz, Steven; Rieser, Caroline; Ashwat, Eishan; Hampton, Erica; Khachfe, Hussein; Laffey, Mckenna; Singhi, Aatur; Bahary, Nathan; Lee, Kenneth; Zureikat, Amer; Paniccia, Alessandro.
Afiliação
  • Liu H; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • D'Alesio M; School of Medicine, University of Pittsburgh, United States.
  • AlMasri S; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Hammad A; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Desilva A; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Lebowitz S; School of Medicine, University of Pittsburgh, United States.
  • Rieser C; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Ashwat E; School of Medicine, University of Pittsburgh, United States.
  • Hampton E; School of Medicine, University of Pittsburgh, United States.
  • Khachfe H; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Laffey M; School of Medicine, University of Pittsburgh, United States.
  • Singhi A; Department of Pathology, University of Pittsburgh Medical Center, United States.
  • Bahary N; Department of Medicine, University of Pittsburgh Medical Center, United States.
  • Lee K; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Zureikat A; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States.
  • Paniccia A; Department of Surgery, University of Pittsburgh Medical Center (UPMC), United States. Electronic address: panicciaa2@upmc.edu.
HPB (Oxford) ; 25(5): 521-532, 2023 05.
Article em En | MEDLINE | ID: mdl-36804826

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article